ITPA and acute lymphoblastic leukemia: Tanaka et al. (2012) have measured the activity of ITPA in 65 Japanese children with pediatric ALL, showing that patients with lower activity of this enzyme tolerated lower doses of mercaptopurine during maintenance therapy and presented increased probability of hepatoxicity.